Elevance Health (ELV) Cash from Investing Activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Cash from Investing Activities data on file, last reported at $159.0 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 123.14% year-over-year to $159.0 million in Q2 2026; TTM through Jun 2026 was -$2.2 billion, a 14.49% increase from a year earlier, with the FY2025 full-year figure at -$1.3 billion, up 73.99% from the prior year.
• Cash from Investing Activities for Q2 2026 stood at $159.0 million, up from -$1.6 billion in the prior quarter.
• Over the last five years, Cash from Investing Activities for ELV reached as high as $464.0 million in Q4 2025 and fell as low as -$3.2 billion in Q1 2023.
• Historically, Cash from Investing Activities has averaged -$1.0 billion across 5 years, with a median of -$923.5 million in 2023.
• Across the five-year window, Cash from Investing Activities jumped 129.92% in 2022 and tumbled 1694.17% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at $289.0 million in 2022, then sank by 456.06% to -$1.0 billion in 2023, then sank by 59.18% to -$1.6 billion in 2024, then jumped by 128.33% to $464.0 million in 2025, then plunged by 65.73% to $159.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $159.0 million in Q2 2026, -$1.6 billion in Q1 2026, and $464.0 million in Q4 2025.